Mesoblast Ltd - ADR

NASDAQ:MESO   3:59:52 PM EDT
8.69
+0.05 (+0.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.13B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$20.27 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$8.57
50-Day MA$9.30
200-Day MA$12.35
See more pivots

Mesoblast Ltd. Stock, NASDAQ:MESO

55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000
Australia
Phone: +61.3.9639.6036
Number of Employees: 102

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.